Roche Biomedical Laboratories: The Global Settlement and the Fight to Join It

Labcorp’s $173 million civil settlement in 1996 covered laboratory billing allegations involving Roche Biomedical Laboratories and the other predecessor laboratories, including added tests combined with routine blood panels. The federal Health Care Fraud and Abuse Control report for fiscal 1997 gives the civil amount. The government alleged that the laboratories turned those added tests into extra charges. The alleged scheme put the cost of added tests on Medicare and the taxpayers behind it.

Why the Roche Settlement Appears Under Labcorp

Roche Biomedical and Allied Clinical Laboratories became part of Laboratory Corporation of America through separate corporate transactions. National Health Laboratories acquired Allied in 1994. Roche then merged with National Health Laboratories to form Labcorp in 1995, while the Roche qui tam case was underway.

The company’s annual report dates the Roche merger to April 28, 1995. Its corporate history explains why a settlement discussed under the Labcorp name reaches the conduct of Roche, Allied and National Health Laboratories.

That matters when an insider describes billing before and after an acquisition. We connect the laboratory that performed the work, the company that billed and the people responsible for the decisions. The underlying test orders and billing records are where we look for the continuity.

The Ruling That Changed the Roche Case

Two Allied Clinical Laboratories billing clerks, whistleblowers whose own case against Allied had settled in March 1995, sought to join the Roche case. The November 1996 global settlement covered that case and also allegations the government learned of through audits under the integrity agreement Allied signed in the clerks’ settlement. The district court let the clerks intervene. The Fourth Circuit’s 1999 decision reversed, holding that the False Claims Act lets no one but the government intervene in a qui tam case.

We work through the connection between your information, the conduct and the earlier case with whistleblower lawyers who know laboratory fraud.

The Blood Panel Behind the Billing Allegations

The government’s account of the laboratory enforcement effort traces Operation LabScam to National Health Laboratories’ 1992 guilty plea in a criminal case involving tests added to panels and billed to Medicare while physicians were misled into believing the tests were free.

That healthcare fraud investigation reached the businesses that later became Labcorp. The allegations against Labcorp’s predecessor laboratories concerned additional tests combined with commonly ordered blood panels. A routine order could carry more testing into the bill than the physician understood the order to include.

A profile name can conceal the individual tests inside it. To understand the billing, we examine what the physician selected, which tests the laboratory performed and which services it charged to Medicare. The useful detail is the connection between those records: how an order became a series of charges, and who inside the business understood that process.

In a parallel case, the Justice Department’s February 12, 1997 settlement announcement alleged that Meris Laboratories routinely added medically unnecessary HDL cholesterol and serum iron tests to automated panels and billed for them separately, although physicians had not ordered them.

What Laboratory Compliance Reviews Were Built to Examine

Laboratory compliance reviews reached the order forms and test profiles behind the claims. The June 1997 Laboratory Medicine article Model Plan Helps Laboratories Fight Fraud explained that much of the government’s model plan grew out of guidance already given to major independent laboratories through corporate integrity agreements.

The article described a practical response to the billing problem. Laboratories would use standardized test offerings and requisition forms with room for the physician to document the medical necessity of each test. Written notices to ordering physicians would explain the components of a profile and how the laboratory would bill Medicare for it.

That reaches the commercial presentation of the testing. A physician choosing a profile needs to understand the individual services the laboratory intends to bill. The article also described monitoring standing orders, analyzing test-use data and keeping records, alongside audits and investigation of identified problems.

The HHS Office of Inspector General’s 1998 laboratory compliance guidance made the same concern concrete: requisition forms should support an independent medical-necessity decision for each test the laboratory bills. For an insider, that puts familiar documents in focus. The profile description, ordering form, physician notices and billing records can show how the laboratory presented the testing and what it ultimately charged.

What Is the Reward for a Medicare Fraud Whistleblower?

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

Laboratory employees can bring more than a suspicion about a large bill. A person who knows how profiles were designed, how orders were processed or how claims were generated may be able to explain a recurring practice across many claims. We work with that knowledge to identify the decisions behind the billing and build a case with laboratory fraud whistleblower lawyers.

You Know How the Order Became a Bill

If you saw a laboratory turn routine orders into additional Medicare charges, tell our whistleblower experts how the billing worked. We build the case around your knowledge, bring in laboratory fraud whistleblower lawyers who understand test ordering and payment, and stay beside you through the case.